Cargando…
Bmi-1-targeting suppresses osteosarcoma aggressiveness through the NF-κB signaling pathway
Bone cancer is one of the most lethal malignancies and the specific causes of tumor initiation are not well understood. B-cell-specific Moloney murine leukemia virus integration site 1 protein (Bmi-1) has been reported to be associated with the initiation and progression of osteosarcoma, and as a pr...
Autores principales: | Liu, Jiaguo, Luo, Bin, Zhao, Meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779877/ https://www.ncbi.nlm.nih.gov/pubmed/28983587 http://dx.doi.org/10.3892/mmr.2017.7660 |
Ejemplares similares
-
[Retracted] Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway
por: Liu, Jiaguo, et al.
Publicado: (2023) -
Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway
por: Li, Yi-Jiong, et al.
Publicado: (2018) -
Punicalagin inhibited proliferation, invasion and angiogenesis of osteosarcoma through suppression of NF-κB signaling
por: Huang, Tao, et al.
Publicado: (2020) -
Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin binding
por: Bartholf DeWitt, Suzanne, et al.
Publicado: (2022) -
Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway
por: Jiang, Lili, et al.
Publicado: (2012)